Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.
Catheter Cardiovasc Interv
; 46(3): 352-5, 1999 Mar.
Article
en En
| MEDLINE
| ID: mdl-10348139
ABSTRACT
Orgaran, a heparinoid, has been used successfully in patients with heparin-induced thrombocytopenia. We report three cases in which Orgaran was combined with the glycoprotein IIbIIa receptor antagonist Reopro during coronary angioplasty. Orgaran was given as a single intravenous bolus of 1500 anti-factor Xa units. No ischemic or hemorrhagic complications occurred during or following the procedure.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Fragmentos Fab de Inmunoglobulinas
/
Inhibidores de Agregación Plaquetaria
/
Angioplastia Coronaria con Balón
/
Sulfatos de Condroitina
/
Enfermedad Coronaria
/
Dermatán Sulfato
/
Heparinoides
/
Heparitina Sulfato
/
Anticuerpos Monoclonales
/
Anticoagulantes
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Catheter Cardiovasc Interv
Asunto de la revista:
CARDIOLOGIA
Año:
1999
Tipo del documento:
Article
País de afiliación:
Canadá